Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Liz has been a health journalist and medical editor for more than 20 years, covering HIV, viral hepatitis, cancer and other health issues.
Fecal microbiota transplantation can help reverse brain impairment in people with liver failure.
Among HIV-positive people, mortality related to hepatitis B and C is falling but deaths due to NAFLD are rising.
People who took Viread were about two thirds less likely to develop HCC, but this could be related to other factors as well.
Keytruda and Opdivo showed antitumor activity in some patients and acceptable side effects in real-world use.
People who added ABI-H0731 saw greater viral load reductions than those who used nucleoside/nucleotide analogues alone.
Nearly a quarter of those taking a higher dose of Ocaliva saw an improvement in liver scarring.
The VA has cured HCV in nearly 100,000 veterans, which will dramatically reduce the development of advanced liver disease and liver cancer.
Use of cost-reducing strategies is still common, but has decreased since 2013.
Ned Sharpless has been appointed interim head of the regulatory agency after the unexpected resignation of the commissioner.
HIV-positive people with a higher viral load over a longer period appear more likely to develop hepatocellular carcinoma.
Seventy percent of liver cancer patients had either a partial response or stable disease.
A third of patients taking neoadjuvant Opdivo had complete responses in an early analysis.
Brain cancer patient begins treatment with experimental vaccine.
Cabometyx is the third liver cancer drug approved in the past six months.
Cancer mortality declined by 27 percent over the past 25 years.
Half of people with worse liver function responded well to immunotherapy.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.